Planntz products are intended for adults. Please confirm your age to continue.
We keep this confirmation on your device only, to remember your choice. No personal data leaves your browser.
NewsWADA published its 2027 Prohibited List on September 21, 2026. CBD is still not prohibited and THC still is, in-competition. The sentence that banned all natural and synthetic cannabinoids is gone, and WADA has not said what that means for CBG, CBN or THCV.
NewsOn September 9, 2026 the D.C. Circuit denied a stay of the April order placing state-licensed medical marijuana in Schedule III. The challenges are still pending, broader rescheduling is still a proposal, and the rule says it does not affect hemp.
NewsA randomized, double-blind crossover trial published on August 27, 2026 gave 18 healthy adults 12.5 mg of THC, with and without 12.5 mg of CBD, then made them breathe against a resistance. Both oils raised heart rate. Here is what the record supports and what it does not.
NewsOn August 28, 2026 results were posted for a randomized trial that put 460 shoppers through a simulated mini mart. In the room with no CBD advertising at all, shoppers endorsed 5.6 of 12 listed benefits and 163 of 230 bought a CBD-branded product anyway.
NewsOn August 11, 2026 FDA proposed making GRAS notification mandatory, and it names Delta-8 THC foods among its five examples. It is a proposal: comments close December 9, 2026, two days before the federal hemp-definition change takes effect.
NewsOn August 26, 2026 DEA placed three kratom-derived analogs in Schedule I by temporary order: mitragynine pseudoindoxyl, MGM-15 and MGM-16. It did not schedule 7-hydroxymitragynine and it did not name kratom leaf. The HHS comment window closes September 10, 2026.
NewsOn September 2, 2026 a single-sentence section inside H.R. 6500 split the 2026 hemp deadline in two. Most of the new definition now arrives on December 11, 2026. One exclusion still arrives on November 12, and it is the one whose official list does not exist.